← Back to headlines
Pulmonx Outlines 2026 Revenue Target and Cost Realignment
Pulmonx has set a 2026 revenue target of $90M-$92M, accompanied by a cost realignment strategy and a renewed focus on U.S. sales to achieve its financial goals.
5 Mar, 01:02 — 5 Mar, 01:02
ℹOnly 1 source covers this story
